Revvity Blog
Powering innovation from discovery to cure.
Latest
How conditional bispecific antibodies are advancing precision immunotherapy.
Cancer
August 14, 2025 - 2 min read
Cell and Gene Therapy
Cell and gene therapy gets on point with base editors.
February 19, 2025 -
6 min read
Cancer
Lentiviral sgRNA CRISPR screening in primary human immune cells.
February 19, 2025 -
2 min read
Reproductive Health
Empowering lives: Revvity's commitment to rare disease awareness.
February 19, 2025 -
3 min read
Cell and Gene Therapy
Base editing goes big: A role in functional pooled screening.
February 14, 2025 -
5 min read
Cell and Gene Therapy
Exploring the potential of base editing for sickle cell disease.
February 14, 2025 -
4 min read
Cell and Gene Therapy
Revvity supports Abata Therapeutics to impact the trajectory of autoimmune disease with engineered Treg cell therapies.
February 7, 2025 -
1 min read
Disease Research, Drug Development, Precision Medicine
What to consider when selecting a centrifuge for your lab.
January 24, 2025 -
3 min read
Cancer
Considerations for engineering a successful knockout cell line generation.
January 17, 2025 -
2 min read
Cancer
Homology-directed repair with a plasmid donor: considerations for successful HDR experimental design.
January 15, 2025 -
4 min read